Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis
In recent years, various devices have been approved for peripheral artery disease with femoropopliteal lesions. However, treatment of long, calcified, and diffused lesions is still challenging because these lesions are associated with restenosis. This report described the case of an 82-year-old man...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-06-01
|
| Series: | SAGE Open Medical Case Reports |
| Online Access: | https://doi.org/10.1177/2050313X211025929 |
| _version_ | 1818865020425994240 |
|---|---|
| author | Naoki Yoshioka Kensuke Takagi Takahiro Tokuda Yasuhiro Morita Itsuro Morishima |
| author_facet | Naoki Yoshioka Kensuke Takagi Takahiro Tokuda Yasuhiro Morita Itsuro Morishima |
| author_sort | Naoki Yoshioka |
| collection | DOAJ |
| description | In recent years, various devices have been approved for peripheral artery disease with femoropopliteal lesions. However, treatment of long, calcified, and diffused lesions is still challenging because these lesions are associated with restenosis. This report described the case of an 82-year-old man with bilateral severely calcified and diffused long lesions in the superficial femoral artery that was treated using polymer-coated paclitaxel-eluting stent and interwoven nitinol stent. After 6 months, in-stent restenosis was observed at the implantation site of the interwoven nitinol stents. Polymer-coated paclitaxel-eluting stents were deployed at the in-stent restenosis site. After another 6 months, angiography and intravascular ultrasound imaging revealed no restenosis at the polymer-coated paclitaxel-eluting stent site. Optical coherence tomography was also performed, revealing that the stent struts were well covered by neointima, which was very thin at approximately 0.1 mm. This representative case demonstrated substantial differences in the effects of devices; in other words, the superiority of polymer-coated paclitaxel-eluting stent in treating long, diffuse, and calcified lesions indicated that its implantation is a reasonable option when the initial gain was obtained following sufficient vessel preparation. |
| first_indexed | 2024-12-19T10:40:54Z |
| format | Article |
| id | doaj.art-c8494eda462f49919e725bd12af3b7ac |
| institution | Directory Open Access Journal |
| issn | 2050-313X |
| language | English |
| last_indexed | 2024-12-19T10:40:54Z |
| publishDate | 2021-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | SAGE Open Medical Case Reports |
| spelling | doaj.art-c8494eda462f49919e725bd12af3b7ac2022-12-21T20:25:27ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2021-06-01910.1177/2050313X211025929Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysisNaoki Yoshioka0Kensuke Takagi1Takahiro Tokuda2Yasuhiro Morita3Itsuro Morishima4Department of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Nagoya Heart Center, Nagoya, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanDepartment of Cardiology, Ogaki Municipal Hospital, Ogaki, JapanIn recent years, various devices have been approved for peripheral artery disease with femoropopliteal lesions. However, treatment of long, calcified, and diffused lesions is still challenging because these lesions are associated with restenosis. This report described the case of an 82-year-old man with bilateral severely calcified and diffused long lesions in the superficial femoral artery that was treated using polymer-coated paclitaxel-eluting stent and interwoven nitinol stent. After 6 months, in-stent restenosis was observed at the implantation site of the interwoven nitinol stents. Polymer-coated paclitaxel-eluting stents were deployed at the in-stent restenosis site. After another 6 months, angiography and intravascular ultrasound imaging revealed no restenosis at the polymer-coated paclitaxel-eluting stent site. Optical coherence tomography was also performed, revealing that the stent struts were well covered by neointima, which was very thin at approximately 0.1 mm. This representative case demonstrated substantial differences in the effects of devices; in other words, the superiority of polymer-coated paclitaxel-eluting stent in treating long, diffuse, and calcified lesions indicated that its implantation is a reasonable option when the initial gain was obtained following sufficient vessel preparation.https://doi.org/10.1177/2050313X211025929 |
| spellingShingle | Naoki Yoshioka Kensuke Takagi Takahiro Tokuda Yasuhiro Morita Itsuro Morishima Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis SAGE Open Medical Case Reports |
| title | Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis |
| title_full | Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis |
| title_fullStr | Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis |
| title_full_unstemmed | Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis |
| title_short | Clinical performance of polymer-coated paclitaxel-eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions: Insights from a patient on hemodialysis |
| title_sort | clinical performance of polymer coated paclitaxel eluting stent implanted for diffuse and calcified superficial femoral artery stenotic lesions insights from a patient on hemodialysis |
| url | https://doi.org/10.1177/2050313X211025929 |
| work_keys_str_mv | AT naokiyoshioka clinicalperformanceofpolymercoatedpaclitaxelelutingstentimplantedfordiffuseandcalcifiedsuperficialfemoralarterystenoticlesionsinsightsfromapatientonhemodialysis AT kensuketakagi clinicalperformanceofpolymercoatedpaclitaxelelutingstentimplantedfordiffuseandcalcifiedsuperficialfemoralarterystenoticlesionsinsightsfromapatientonhemodialysis AT takahirotokuda clinicalperformanceofpolymercoatedpaclitaxelelutingstentimplantedfordiffuseandcalcifiedsuperficialfemoralarterystenoticlesionsinsightsfromapatientonhemodialysis AT yasuhiromorita clinicalperformanceofpolymercoatedpaclitaxelelutingstentimplantedfordiffuseandcalcifiedsuperficialfemoralarterystenoticlesionsinsightsfromapatientonhemodialysis AT itsuromorishima clinicalperformanceofpolymercoatedpaclitaxelelutingstentimplantedfordiffuseandcalcifiedsuperficialfemoralarterystenoticlesionsinsightsfromapatientonhemodialysis |